Ordered accumulation of mutations in HIV protease confers resistance to ritonavir
Nature Medicine1996Vol. 2(7), pp. 760–766
Citations Over TimeTop 1% of 1996 papers
Akhteruzzaman Molla, Marina Korneyeva, Qing Gao, Sudthida Vasavanonda, Paaline J. Schipper, Hongmei Mo, Martin Markowitz, Tatyana Chernyavskiy, Ping Niu, Nicholas A. Lyons, Ann Hsu, G. Richard Granneman, David D. Ho, Charles A. Boucher, John M. Leonard, Daniel W. Norbeck, Dale J. Kempf
Related Papers
- Superior virological efficacy of ritonavir-boosted protease inhibitor regimens compared to single protease inhibitor therapy.(2003)
- → Drug Resistance and Predicted Virologic Responses to Human Immunodeficiency Virus Type 1 Protease Inhibitor Therapy(2000)139 cited
- → Drug Interaction Potential with Inhibitors of HIV Protease(1997)35 cited
- → Once-daily directly observed therapy lopinavir/ritonavir plus indinavir as a protease inhibitor-only salvage therapy in heavily pretreated HIV-1-infected patients: a pilot study(2005)9 cited
- Protease inhibitors shine in triple combinations.(1996)